" class="no-js "lang="en-US"> Steffen Mueller - Medtech Alert
Thursday, September 25, 2025
Steffen Mueller

Steffen Mueller

About Steffen Mueller

Dr. Steffen Mueller is a pioneer in the field synthetic virology and a gifted experimentalist. As a skilled, driven scientist, Dr. Mueller oversees all R&D activities at Codagenix and still works-hands on at the bench to ensure project success. He currently leads a team of 6 scientists, simultaneously managing projects involving multiple, unrelated viruses including: Zika, Dengue, Influenza A, Influenza B, RSV, Yellow Fever, and PRRS viruses. He and his team have successfully generated first in class vaccine candidates against many pathogens – going from synthetically designed DNA to efficacious live vaccines. Dr. Mueller earned his BS in Biology from the University of Cologne, Germany, a MS in Genetics, Developmental Biology, Biochemistry from the University of Cologne, Germany and his PhD in Molecular Microbiology from Stony Brook University.

Related Story

Intranasal COVID-19 Vaccine Demonstrates Single-dose Efficacy in Preclinical Studies, in Parallel with Achievement of Phase 1 Clinical Milestone

July 1 2021

Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic […]